http://www.mmafighting.com/2016/12/...t=chorus&utm_medium=social&utm_source=twitter Jones faced sanctions from both the NAC and the United States Anti-Doping Agency for his failed out-of-competition drug test. He made history in October by becoming the first UFC fighter to appeal a USADA suspension, however, an independent arbitration panel sided with USADA and upheld the one-year suspension proposed, which also expires on July 6, 2017. Jones had his USADA case heard by three arbitrators from McLaren Global Sports Solutions. Jones tested positive for two banned substances, Hydroxy-clomiphene, an anti-estrogenic agent, as well the Letrozole metabolite, an aromatase inhibitor, prior to UFC 200 and was pulled from the card just three days before his highly-anticipated rematch against Daniel Cormier. At his USADA hearing, Jones claimed he took a contaminated sexual-performance pill, which USADA independently confirmed was tainted. However, the arbitrators ruled Jones didn't do his due diligence in determining whether or not the pill was within the confines of the UFC's anti-doping policy and the WADA Code. Some wondered whether Nevada would suspend Jones, who hasn't fought since April, for more than a year given his recent misjudgments, but in the end, the NAC sided with USADA, paving the way for Jones to return in seven months.
